Enova chair exercises options, sells 28,500 shares
Enova International Executive Chairman David Fisher reported an exercise-and-sell sequence over July 14–15, 2026.
Rhea-AI Filing Summary
Enova International Executive Chairman David Fisher reported an exercise-and-sell sequence over July 14–15, 2026. He exercised options for a total of 28,500 common shares at $20.73 per share and sold the same number in open-market transactions at weighted-average prices of $231.454 and $231.5061 per share.
Following these transactions, Fisher directly holds 306,444 Enova common shares and 184,682 non-qualified stock options with a $20.73 exercise price expiring on February 11, 2027. The options vested in substantially equal one-third increments in 2021, 2022, and 2023.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and sale activity reported; no spread calculated
Exercise and Sale
6 txns
Insider
Fisher David
Role
Executive Chairman
Sold
28,500 shs ($6.60M)
Approx. gross sale proceeds
$6.60M
Approx. exercise cost
$591K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) with limited SAR F3, F4, F5 | 11,494 | $0.00 | $0.00 |
| Exercise | Common stock, par value $0.00001 per share | 11,494 | $20.73 | $238K |
| Sale | Common stock, par value $0.00001 per share F2 | 11,494 | $231.454 | $2.66M |
| Exercise | Non-Qualified Stock Option (right to buy) with limited SAR F3, F4, F5 | 17,006 | $0.00 | $0.00 |
| Exercise | Common stock, par value $0.00001 per share | 17,006 | $20.73 | $353K |
| Sale | Common stock, par value $0.00001 per share F1 | 17,006 | $231.5061 | $3.94M |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) with limited SAR — 184,682 contracts (Direct);
Common stock, par value $0.00001 per share — 306,444 shares (Direct)
Footnotes (5)
- F1. This transaction was executed in multiple trades at prices ranging from $229.9452 to $233.6532. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.
- F2. This transaction was executed in multiple trades at prices ranging from $225.64 to $235.4298. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.
- F3. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
- F4. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
- F5. The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022, and February 11, 2023.
Key Figures
Shares sold July 14, 2026: 17,006 shares at $231.5061 per share
Shares sold July 15, 2026: 11,494 shares at $231.4540 per share
Options exercised July 14, 2026: 17,006 shares at $20.73 exercise price
+3 more
6 metrics
Shares sold July 14, 2026
17,006 shares at $231.5061 per share
Open-market sale of common stock by Executive Chairman David Fisher
Shares sold July 15, 2026
11,494 shares at $231.4540 per share
Open-market sale of common stock by Executive Chairman David Fisher
Options exercised July 14, 2026
17,006 shares at $20.73 exercise price
Exercise of non-qualified stock options for Enova common stock
Options exercised July 15, 2026
11,494 shares at $20.73 exercise price
Exercise of non-qualified stock options for Enova common stock
Common shares held after transactions
306,444 shares
Direct Enova common stock holdings by David Fisher following reported trades
Options outstanding after transactions
184,682 options at $20.73, expiring 2027-02-11
Remaining non-qualified stock options with tandem SAR held by David Fisher
Key Terms
Non-Qualified Stock Option, stock appreciation right ("SAR"), weighted average sale price, tender offer or exchange offer
4 terms
Non-Qualified Stock Option financial
"Security title: "Non-Qualified Stock Option (right to buy) with limited SAR""
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
stock appreciation right ("SAR") financial
"The limited stock appreciation right ("SAR") and employee stock option were granted"
weighted average sale price financial
"The price reported above reflects the weighted average sale price."
tender offer or exchange offer regulatory
""Offer" means any tender offer or exchange offer for outstanding shares of Issuer"
FAQ
What transactions did Enova (ENVA) Executive Chairman David Fisher report in this Form 4?
David Fisher reported exercising options for 28,500 Enova shares at $20.73 per share and selling 28,500 common shares in open-market trades at weighted-average prices of $231.454 and $231.5061 per share over July 14–15, 2026.
What Enova (ENVA) stock options does David Fisher still hold after these trades?
Fisher continues to hold 184,682 non-qualified stock options on Enova common stock with an exercise price of $20.73 per share, expiring on February 11, 2027. These options are paired with a limited stock appreciation right as described in the filing footnotes.
How did David Fisher’s Enova (ENVA) option grants vest?
The options underlying these transactions vested in substantially equal one-third increments on February 11, 2021, February 11, 2022, and February 11, 2023. This vesting schedule applied to the non-qualified stock options exercised in the July 2026 trades.
What is the limited stock appreciation right (SAR) mentioned in David Fisher’s Enova (ENVA) filing?
The filing explains that the limited stock appreciation right (SAR) is granted in tandem with the employee stock option. Exercising one causes the other to expire and, if certain change-in-control and offer conditions are met, can pay an amount based on the share price above $20.73.
AI-generated analysis. How Rhea-AI works. Not financial advice.
